AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $204,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
| CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
| Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
| Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
| COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
| Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |